These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. Sharif NA, Xu SX, Williams GW, Crider JY, Griffin BW, Davis TL. J Pharmacol Exp Ther; 1998 Aug 27; 286(2):1094-102. PubMed ID: 9694973 [Abstract] [Full Text] [Related]
7. Specific prostaglandin E2 binding sites in isolated rat glomeruli: evidence for glomerular PGE receptors. Chaudhari A, Kirschenbaum MA. Prostaglandins Leukot Med; 1985 Oct 27; 20(1):55-68. PubMed ID: 2866541 [Abstract] [Full Text] [Related]
8. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor. Virgolini I, Li S, Sillaber C, Majdic O, Sinzinger H, Lechner K, Bettelheim P, Valent P. J Biol Chem; 1992 Jun 25; 267(18):12700-8. PubMed ID: 1377673 [Abstract] [Full Text] [Related]
9. Stimulatory effect of guanine nucleotides on prostaglandin E1 binding to murine renal outer medulla. Kimura K, Fujiwara N, Negishi M, Yatsunami K, Ichikawa A. J Pharmacobiodyn; 1991 Jan 25; 14(1):53-60. PubMed ID: 1861239 [Abstract] [Full Text] [Related]
10. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. Teixeira MM, al-Rashed S, Rossi AG, Hellewell PG. Br J Pharmacol; 1997 May 25; 121(1):77-82. PubMed ID: 9146890 [Abstract] [Full Text] [Related]
15. D-galactosamine-induced cell damage enhances specific binding of prostaglandin E1 to rat hepatocytes. Matsumoto M, Kikuchi E, Okamoto Y, Morimura M, Kitano H, Fukui H, Nakano H, Tsujii T. Biochem Biophys Res Commun; 1992 Apr 30; 184(2):654-60. PubMed ID: 1315527 [Abstract] [Full Text] [Related]
16. Human hepatocellular cancers show decreased prostaglandin E1 binding capacity. Virgolini I, Sinzinger H, Müller C, Hermann M. Br J Cancer; 1989 Mar 30; 59(3):407-9. PubMed ID: 2539179 [Abstract] [Full Text] [Related]
17. The effect of copper on the binding of prostaglandin E1 to NMU-induced rat mammary carcinoma membranes. Liu SC, Knazek RA. Prostaglandins Leukot Med; 1983 Oct 30; 12(2):159-67. PubMed ID: 6139823 [Abstract] [Full Text] [Related]
18. A transplantable rat Leydig cell tumour. Properties of the prostaglandin E receptor. Erichsen A, Hansson V. Acta Endocrinol (Copenh); 1989 Apr 30; 120(4):499-504. PubMed ID: 2541591 [Abstract] [Full Text] [Related]
19. Selected properties of [3H]prostaglandin E1 binding to dispersed bovine luteal cells. Lin MT, Rao CV. Mol Cell Endocrinol; 1978 Jan 30; 9(3):311-20. PubMed ID: 203503 [Abstract] [Full Text] [Related]
20. Receptors of prostaglandin E1 in the plasma membrane of normal liver. Effect of membrane fluidity on PGE1 binding. Nassar CF, Nasser MG, Habbal ZM. Gen Pharmacol; 1985 Jan 30; 16(6):625-7. PubMed ID: 2867952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]